Spotlight on Risperidone in Irritability Associated with Autistic Disorder in Children and Adolescents

被引：0

作者：

Lesley J. Scott

Sohita Dhillon

机构：

[1] Wolters Kluwer Health Adis,

[2] 41 Centorian Drive,undefined

[3] Wolters Kluwer Health,undefined

来源：

CNS Drugs | 2008年 / 22卷

关键词：

Risperidone; Autistic Child; Autistic Disorder; Vineland Adaptive Behaviour Scale; Risperidone Treatment;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Risperidone (Risperdal®), a psychotropic atypical antipsychotic agent, is thought to act via dopamine D2 and serotonin 5-HT2A receptor antagonism. The clinical efficacy of oral risperidone in the treatment of bipolar mania and schizophrenia in adult patients is well established. In the US, risperidone is also approved for the treatment of irritability associated with autistic disorder in children and adolescents aged 5–16 years, for the treatment of schizophrenia in adolescents aged 13–17 years and, as monotherapy, for the short-term treatment of acute manic and mixed episodes associated with bipolar I disorder in children and adolescents aged 10–17 years.

引用

页码：259 / 262

页数：3

共 50 条

[41] Effectiveness of risperidone for the treatment of ADHD in children and adolescents with bipolar disorder
Mick, E
Biederman, J
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S212 - S213
[42] An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan
Ichikawa, Hironobu
Hiratani, Michio
Yasuhara, Akihiro
Tsujii, Noa
Oshimo, Takashi
Ono, Hiroaki
Tadori, Yoshihiro
[J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2018, 72 (02) : 84 - 94
[43] Risperidone-Associated Urinary Incontinence in Patients With Autistic Disorder With Mental Retardation
Kumazaki, Hirokazu
Watanabe, Koichiro
Imasaka, Yasushi
Iwata, Kazuhiko
Tomoda, Akemi
Mimura, Masaru
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (05) : 624 - 626
[44] Risperidone for children and adolescents with autism spectrum disorder: a systematic review
Maneeton, Narong
Maneeton, Benchalak
Putthisri, Suwannee
Woottiluk, Pakapan
Narkpongphun, Assawin
Srisurapanont, Manit
[J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 1811 - 1820
[45] Aripiprazole for Irritability in Asian Children and Adolescents with Autistic Disorder: A 12-Week, Multinational, Multicenter, Prospective Open-Label Study
Kim, Hyo-Won
Park, Eun-Jin
Kim, Ji-Hoon
Boon-Yasidhi, Vitharon
Tarugsa, Jariya
Reyes, Alexis
Manalo, Stella
Joung, Yoo-Sook
[J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (06) : 402 - 408
[46] IRRITABILITY IN AUTISTIC-CHILDREN TREATED WITH FENFLURAMINE
VOLKMAR, FR
PAUL, R
COHEN, DJ
SHAYWITZ, BA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (03): : 187 - 187
[47] Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder - An open label maintenance study
Gencer, Ozlem
Emiroglu, F. Neslihan Inal
Miral, Suha
Baykara, Burak
Baykara, Aysen
Dirik, Eray
[J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2008, 17 (04) : 217 - 225
[48] Irritability in Children and Adolescents With OCD
Guzick, Andrew G.
Geller, Daniel A.
Small, Brent J.
Murphy, Tanya K.
Wilhelm, Sabine
Storch, Eric A.
[J]. BEHAVIOR THERAPY, 2021, 52 (04) : 883 - 896
[49] Efficacy of risperidone on the core symptoms of autistic disorder
Kolar, D.
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S621 - S621
[50] Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents
Nuntamool, Nopphadol
Ngamsamut, Nattawat
Vanwong, Natchaya
Puangpetch, Apichaya
Chamnanphon, Monpat
Hongkaew, Yaowaluck
Limsila, Penkhae
Suthisisang, Chuthamanee
Wilffert, Bob
Sukasem, Chonlaphat
[J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 (04) : 316 - 324

← 1 2 3 4 5 →